CoralGenomics

We measure and reduce variability in drug response.

[CoralGenomics @CoralGenomics]

Announcing our partnership with the Crohn's and Colitis Foundation! In a study that will include up to 1,000 patients, we'll study factors influencing response to therapy complementing our existing REEF studies.

See more below:
https://t.co/gvjdzdP0NH

[CoralGenomics @CoralGenomics]

introducing "anti-precision medicine" and how it can be used to improve a $40B/yr drug class

https://t.co/keP5S1bYw7

[CoralGenomics @CoralGenomics]

Honored to participate! Our CEO will be speaking today at (9/14) and tomorrow (9/15) @ 4pm EDT with the Lyfebulb/Arena IBD innovation Challenge team/judges and the UCSF Health Awards respectively. See below for links to register:

https://t.co/dKdhmXtr6C

https://t.co/dsYT7rCLhU

[CoralGenomics @CoralGenomics]

We're excited to announce our partnership with Drugviu to increase minority representation in our clinical studies! Looking forward to expanding our work together over the next couple of years.

https://t.co/2s3zJUBJgR

[CoralGenomics @CoralGenomics]

A summer intern project on applying deep learning to predict adverse events developed into Coral's first peer reviewed publication!

Applications include parsing clinical/claims datasets for improving risk predictions + targeted interventions.

Read more:
https://t.co/VESquAh7Gb

[CoralGenomics @CoralGenomics]

We'll be presenting a poster on our IBD clinical study at 3:45pm eastern on November 17th as part of the virtual IBD Innovate conference sponsored by the Crohn's and Colitis Foundation.

We're also looking forward to learning from the other presenters as well!

#IBDInnovate

[CoralGenomics @CoralGenomics]

Coral Genomics Awarded $2Million Phase II SBIR Grant to Advance Low-Depth Applications for Clinical Sequencing https://t.co/YojqXxyaZG

[CoralGenomics @CoralGenomics]

Coral Genomics Awarded $2Million Phase II SBIR Grant to Advance Low-Depth Applications for Clinical Sequencing https://t.co/YojqXxyaZG

[CoralGenomics @CoralGenomics]

We stand with the Black Lives Matter movement and will continue to condemn racial disparities. Read our more detailed statement on confronting these issues below:

https://t.co/fe3xoe1NyO

[CoralGenomics @CoralGenomics]

Coral Genomics was a proud participant at the Time 100 Summit! #billclinton, #NIH, #ParkerInstitute, #PersonalizedMedicine, #PatientCentric
https://t.co/gNvWFV1eod

[CoralGenomics @CoralGenomics]

Backstage preparation before Coral's CEO heads on-stage to discuss our science and tests. #billclinton, #NIH, #ParkerInstitute, #PersonalizedMedicine, #PatientCentric
https://t.co/gNvWFV1eod

[CoralGenomics @CoralGenomics]

Until the next event, thanks for having us @TIME! #billclinton, #NIH, #ParkerInstitute, #PersonalizedMedicine, #PatientCentric
https://t.co/gNvWFV1eod

[CoralGenomics @CoralGenomics]

Can't wait to see what Time does in 2020 to profile health innovations and healthcare startups.#billclinton, #NIH, #ParkerInstitute, #PersonalizedMedicine, #PatientCentric
https://t.co/gNvWFV1eod

[CoralGenomics @CoralGenomics]

Coral Genomics was a proud participant at the Time 100 Summit! #diversity, #billclinton, #NIH,#ParkerInstitute, #PersonalizedMedicine, #PatientCentric
https://t.co/gNvWFV1eod

[CoralGenomics @CoralGenomics]

MIT ILP Productivity in Biopharma @CoralGenomics
https://t.co/5YebXwsiSP

[CoralGenomics @CoralGenomics]

MIT ILP Productivity in Biopharma @CoralGenomics
https://t.co/5YebXwsiSP

[CoralGenomics @CoralGenomics]

https://t.co/74aZZ1L5qI @CoralGenomics

[CoralGenomics @CoralGenomics]

Watch our Founder, Atray Dixit, Ph.D., talk about Coral today at the Time 100 Health Summit (12:25 EST) https://t.co/NdhYoJyttv #TIME100Health #InventingTheFuture #Genetics #ChangingHealthcare

[CoralGenomics @CoralGenomics]

Joining the Twitter-verse! #Welcome #Tuesdaytasks #Genetics